ID   CTR2_HUMAN              Reviewed;         658 AA.
AC   P52569; B7ZL54; O15291; O15292; Q14CQ6; Q6NSZ7; Q86TC6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Cationic amino acid transporter 2;
DE            Short=CAT-2;
DE            Short=CAT2;
DE   AltName: Full=Low affinity cationic amino acid transporter 2;
DE   AltName: Full=Solute carrier family 7 member 2;
GN   Name=SLC7A2; Synonyms=ATRC2, CAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Intestine;
RX   PubMed=8954799; DOI=10.1006/geno.1996.0613;
RA   Hoshide R., Ikeda Y., Karashima S., Matsuura T., Komaki S.,
RA   Kishino T., Niikawa N., Endo F., Matsuda I.;
RT   "Molecular cloning, tissue distribution, and chromosomal localization
RT   of human cationic amino acid transporter 2 (HCAT2).";
RL   Genomics 38:174-178(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   337-469 (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND VARIANT
RP   THR-531.
RC   TISSUE=Liver;
RX   PubMed=9174363; DOI=10.1021/bi962829p;
RA   Closs E.I., Graef P., Habermeier A., Cunningham J.M., Foerstermann U.;
RT   "Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B:
RT   three related carriers with distinct transport properties.";
RL   Biochemistry 36:6462-6468(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANT THR-531.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 313-658 (ISOFORM 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-646, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-455, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24; THR-28; SER-446;
RP   SER-464; SER-646 AND SER-647, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-646, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Functions as permease involved in the transport of the
CC       cationic amino acids (arginine, lysine and ornithine); the
CC       affinity for its substrates differs between isoforms created by
CC       alternative splicing. Isoform 1 functions as permease that
CC       mediates the transport of the cationic amino acids (arginine,
CC       lysine and ornithine), and it has much higher affinity for
CC       arginine than isoform 2. Isoform 2 functions as low-affinity, high
CC       capacity permease involved in the transport of the cationic amino
CC       acids (arginine, lysine and ornithine) (PubMed:9174363). May play
CC       a role in classical or alternative activation of macrophages via
CC       its role in arginine transport. {ECO:0000250|UniProtKB:P18581,
CC       ECO:0000269|PubMed:9174363}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9174363};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:9174363}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=CAT-2B;
CC         IsoId=P52569-1; Sequence=Displayed;
CC       Name=2; Synonyms=CAT-2A;
CC         IsoId=P52569-2; Sequence=VSP_037354, VSP_023354;
CC         Note=Ref.2 (AAB62810) sequence differs from that shown due to a
CC         frameshift in position 29. {ECO:0000305};
CC       Name=3;
CC         IsoId=P52569-3; Sequence=VSP_037354;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in the skeletal
CC       muscle, placenta and ovary. Expressed at intermediate levels in
CC       the liver and pancreas and at low levels in the kidney and heart.
CC       {ECO:0000269|PubMed:8954799}.
CC   -!- SIMILARITY: Belongs to the amino acid-polyamine-organocation (APC)
CC       superfamily. Cationic amino acid transporter (CAT) (TC 2.A.3.3)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH69648.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI04906.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI13662.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI43584.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D29990; BAA06271.1; -; mRNA.
DR   EMBL; U76368; AAB62810.1; ALT_FRAME; mRNA.
DR   EMBL; U76369; AAB62811.1; -; mRNA.
DR   EMBL; AB020863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63813.1; -; Genomic_DNA.
DR   EMBL; BC069648; AAH69648.1; ALT_INIT; mRNA.
DR   EMBL; BC104905; AAI04906.1; ALT_INIT; mRNA.
DR   EMBL; BC113661; AAI13662.1; ALT_INIT; mRNA.
DR   EMBL; BC143583; AAI43584.1; ALT_INIT; mRNA.
DR   EMBL; AL832016; CAD89909.1; -; mRNA.
DR   CCDS; CCDS34852.1; -. [P52569-1]
DR   CCDS; CCDS55203.1; -. [P52569-3]
DR   CCDS; CCDS6002.2; -. [P52569-2]
DR   RefSeq; NP_001008539.3; NM_001008539.3. [P52569-1]
DR   RefSeq; NP_001158243.1; NM_001164771.1. [P52569-3]
DR   RefSeq; NP_003037.4; NM_003046.5. [P52569-2]
DR   RefSeq; XP_005273667.1; XM_005273610.4. [P52569-1]
DR   RefSeq; XP_005273668.1; XM_005273611.4. [P52569-1]
DR   RefSeq; XP_005273669.1; XM_005273612.4. [P52569-1]
DR   RefSeq; XP_016869235.1; XM_017013746.1. [P52569-1]
DR   RefSeq; XP_016869236.1; XM_017013747.1.
DR   UniGene; Hs.448520; -.
DR   ProteinModelPortal; P52569; -.
DR   BioGrid; 112433; 23.
DR   IntAct; P52569; 2.
DR   STRING; 9606.ENSP00000004531; -.
DR   DrugBank; DB00123; L-Lysine.
DR   DrugBank; DB00129; L-Ornithine.
DR   TCDB; 2.A.3.3.8; the amino acid-polyamine-organocation (apc) family.
DR   iPTMnet; P52569; -.
DR   PhosphoSitePlus; P52569; -.
DR   SwissPalm; P52569; -.
DR   BioMuta; SLC7A2; -.
DR   DMDM; 126302539; -.
DR   EPD; P52569; -.
DR   MaxQB; P52569; -.
DR   PaxDb; P52569; -.
DR   PeptideAtlas; P52569; -.
DR   PRIDE; P52569; -.
DR   Ensembl; ENST00000004531; ENSP00000004531; ENSG00000003989. [P52569-3]
DR   Ensembl; ENST00000398090; ENSP00000381164; ENSG00000003989. [P52569-2]
DR   Ensembl; ENST00000470360; ENSP00000419873; ENSG00000003989. [P52569-2]
DR   Ensembl; ENST00000494857; ENSP00000419140; ENSG00000003989. [P52569-1]
DR   Ensembl; ENST00000522656; ENSP00000430464; ENSG00000003989. [P52569-1]
DR   GeneID; 6542; -.
DR   KEGG; hsa:6542; -.
DR   UCSC; uc011kyc.3; human. [P52569-1]
DR   CTD; 6542; -.
DR   DisGeNET; 6542; -.
DR   GeneCards; SLC7A2; -.
DR   HGNC; HGNC:11060; SLC7A2.
DR   HPA; HPA009277; -.
DR   MIM; 601872; gene.
DR   neXtProt; NX_P52569; -.
DR   OpenTargets; ENSG00000003989; -.
DR   PharmGKB; PA35920; -.
DR   eggNOG; KOG1286; Eukaryota.
DR   eggNOG; COG0531; LUCA.
DR   GeneTree; ENSGT00760000119151; -.
DR   HOGENOM; HOG000250623; -.
DR   HOVERGEN; HBG000280; -.
DR   InParanoid; P52569; -.
DR   KO; K13864; -.
DR   OMA; AVIAKYW; -.
DR   OrthoDB; EOG091G05NM; -.
DR   PhylomeDB; P52569; -.
DR   TreeFam; TF315212; -.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC7A2; human.
DR   GeneWiki; SLC7A2; -.
DR   GenomeRNAi; 6542; -.
DR   PRO; PR:P52569; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000003989; -.
DR   CleanEx; HS_SLC7A2; -.
DR   Genevisible; P52569; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015174; F:basic amino acid transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0005289; F:high-affinity arginine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0097627; F:high-affinity L-ornithine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0005292; F:high-affinity lysine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0097626; F:low-affinity L-arginine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0097638; P:L-arginine import across plasma membrane; IEA:Ensembl.
DR   GO; GO:0097639; P:L-lysine import across plasma membrane; IEA:Ensembl.
DR   GO; GO:0097640; P:L-ornithine import across plasma membrane; IEA:Ensembl.
DR   GO; GO:0042116; P:macrophage activation; IEA:Ensembl.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0002537; P:nitric oxide production involved in inflammatory response; IEA:Ensembl.
DR   GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0043030; P:regulation of macrophage activation; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR002293; AA/rel_permease1.
DR   InterPro; IPR004755; Cat_AA_permease.
DR   InterPro; IPR029485; CAT_C.
DR   Pfam; PF13520; AA_permease_2; 1.
DR   Pfam; PF13906; AA_permease_C; 1.
DR   TIGRFAMs; TIGR00906; 2A0303; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Cell membrane;
KW   Complete proteome; Glycoprotein; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    658       Cationic amino acid transporter 2.
FT                                /FTId=PRO_0000054264.
FT   TOPO_DOM      1     37       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     38     59       Helical. {ECO:0000255}.
FT   TOPO_DOM     60     63       Extracellular. {ECO:0000255}.
FT   TRANSMEM     64     84       Helical. {ECO:0000255}.
FT   TOPO_DOM     85    104       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    105    125       Helical. {ECO:0000255}.
FT   TOPO_DOM    126    163       Extracellular. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical. {ECO:0000255}.
FT   TOPO_DOM    185    192       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    193    213       Helical. {ECO:0000255}.
FT   TOPO_DOM    214    248       Extracellular. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical. {ECO:0000255}.
FT   TOPO_DOM    270    289       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    290    309       Helical. {ECO:0000255}.
FT   TOPO_DOM    310    339       Extracellular. {ECO:0000255}.
FT   TRANSMEM    340    360       Helical. {ECO:0000255}.
FT   TOPO_DOM    361    386       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    387    407       Helical. {ECO:0000255}.
FT   TOPO_DOM    408    410       Extracellular. {ECO:0000255}.
FT   TRANSMEM    411    431       Helical. {ECO:0000255}.
FT   TOPO_DOM    432    490       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical. {ECO:0000255}.
FT   TOPO_DOM    512    524       Extracellular. {ECO:0000255}.
FT   TRANSMEM    525    549       Helical. {ECO:0000255}.
FT   TOPO_DOM    550    557       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    558    578       Helical. {ECO:0000255}.
FT   TOPO_DOM    579    582       Extracellular. {ECO:0000255}.
FT   TRANSMEM    583    603       Helical. {ECO:0000255}.
FT   TOPO_DOM    604    658       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      28     28       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     446    446       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     455    455       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     464    464       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     646    646       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     647    647       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    239    239       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MKIETSGYNSDKLICRGFIGTPAPPVCDSKFLLSPS
FT                                SDVRM (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:9174363}.
FT                                /FTId=VSP_037354.
FT   VAR_SEQ     357    398       IFPMPRVIYAMAEDGLLFKCLAQINSKTKTPIIATLSSGAV
FT                                A -> MFPLPRILFAMARDGLLFRFLARVSKRQSPVAATLT
FT                                AGVIS (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:9174363}.
FT                                /FTId=VSP_023354.
FT   VARIANT      20     20       V -> M (in dbSNP:rs12680645).
FT                                /FTId=VAR_030799.
FT   VARIANT     376    376       C -> F (in dbSNP:rs1134975).
FT                                /FTId=VAR_030800.
FT   VARIANT     531    531       A -> T (in dbSNP:rs62622371).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9174363}.
FT                                /FTId=VAR_030801.
FT   VARIANT     547    547       Q -> L (in dbSNP:rs1981498).
FT                                /FTId=VAR_058414.
FT   CONFLICT    134    134       W -> G (in Ref. 1; BAA06271).
FT                                {ECO:0000305}.
FT   CONFLICT    364    364       I -> N (in Ref. 1; BAA06271).
FT                                {ECO:0000305}.
FT   CONFLICT    520    520       T -> Y (in Ref. 1; BAA06271).
FT                                {ECO:0000305}.
FT   CONFLICT    552    552       Q -> R (in Ref. 1; BAA06271).
FT                                {ECO:0000305}.
FT   CONFLICT    566    566       A -> T (in Ref. 1; BAA06271).
FT                                {ECO:0000305}.
FT   CONFLICT    568    568       S -> T (in Ref. 1; BAA06271).
FT                                {ECO:0000305}.
FT   CONFLICT    605    605       H -> R (in Ref. 6; CAD89909).
FT                                {ECO:0000305}.
FT   CONFLICT    619    619       D -> V (in Ref. 6; CAD89909).
FT                                {ECO:0000305}.
SQ   SEQUENCE   658 AA;  71673 MW;  633FD86A333E9208 CRC64;
     MIPCRAALTF ARCLIRRKIV TLDSLEDTKL CRCLSTMDLI ALGVGSTLGA GVYVLAGEVA
     KADSGPSIVV SFLIAALASV MAGLCYAEFG ARVPKTGSAY LYTYVTVGEL WAFITGWNLI
     LSYVIGTSSV ARAWSGTFDE LLSKQIGQFL RTYFRMNYTG LAEYPDFFAV CLILLLAGLL
     SFGVKESAWV NKVFTAVNIL VLLFVMVAGF VKGNVANWKI SEEFLKNISA SAREPPSENG
     TSIYGAGGFM PYGFTGTLAG AATCFYAFVG FDCIATTGEE VRNPQKAIPI GIVTSLLVCF
     MAYFGVSAAL TLMMPYYLLD EKSPLPVAFE YVGWGPAKYV VAAGSLCALS TSLLGSIFPM
     PRVIYAMAED GLLFKCLAQI NSKTKTPIIA TLSSGAVAAL MAFLFDLKAL VDMMSIGTLM
     AYSLVAACVL ILRYQPGLSY DQPKCSPEKD GLGSSPRVTS KSESQVTMLQ RQGFSMRTLF
     CPSLLPTQQS ASLVSFLVGF LAFLVLGLSV LTTYGVHAIT RLEAWSLALL ALFLVLFVAI
     VLTIWRQPQN QQKVAFMVPF LPFLPAFSIL VNIYLMVQLS ADTWVRFSIW MAIGFLIYFS
     YGIRHSLEGH LRDENNEEDA YPDNVHAAAE EKSAIQANDH HPRNLSSPFI FHEKTSEF
//
